同日双侧抗血管内皮生长因子注射后发生双侧眼内炎。 - Suppr | 超能文献

Bilateral endophthalmitis following bilateral same-day anti-VEGF injections.

作者信息

Sepetis Anastasios E, Clarke Benjamin, Gupta Bhaskar

机构信息

Department of Ophthalmology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

出版信息

Acta Ophthalmol. 2021 Feb;99(1):e131-e133. doi: 10.1111/aos.14504. Epub 2020 Jun 13.

DOI:10.1111/aos.14504

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Bilateral endophthalmitis following bilateral same-day anti-VEGF injections.同日双侧抗血管内皮生长因子注射后发生双侧眼内炎。

Acta Ophthalmol. 2021 Feb;99(1):e131-e133. doi: 10.1111/aos.14504. Epub 2020 Jun 13.

2

Incidence and Outcomes of Infectious and Noninfectious Endophthalmitis after Intravitreal Injections for Age-Related Macular Degeneration.年龄相关性黄斑变性患者玻璃体内注射后感染性和非感染性眼内炎的发生率和结局。

Ophthalmology. 2018 Jan;125(1):66-74. doi: 10.1016/j.ophtha.2017.07.005. Epub 2017 Aug 8.

3

LOW ENDOPHTHALMITIS RATES AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS IN AN OPERATION ROOM: A Retrospective Multicenter Study.手术室玻璃体内注射抗血管内皮生长因子后低眼内炎发生率：一项回顾性多中心研究

Retina. 2017 Dec;37(12):2341-2346. doi: 10.1097/IAE.0000000000001488.

4

COMPARATIVE RISK OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION WITH BEVACIZUMAB, AFLIBERCEPT, AND RANIBIZUMAB.贝伐单抗、阿柏西普和雷珠单抗玻璃体内注射后眼内炎的比较风险。

Retina. 2019 Oct;39(10):2004-2011. doi: 10.1097/IAE.0000000000002351.

5

Endophthalmitis following Intravitreal Anti-Vascular Endothelial Growth Factor Therapy: Changes in Incidence and Outcomes over a 9-Year Period.玻璃体内抗血管内皮生长因子治疗后眼内炎：9年期间发病率和结局的变化

Curr Eye Res. 2021 Sep;46(9):1370-1377. doi: 10.1080/02713683.2021.1874023. Epub 2021 Jan 31.

6

Safety and complications of intravitreal injections performed in an Asian population in Singapore.新加坡亚洲人群玻璃体内注射的安全性与并发症

Int Ophthalmol. 2017 Apr;37(2):325-332. doi: 10.1007/s10792-016-0241-4. Epub 2016 May 28.

7

Complications of subspecialty ophthalmic care: endophthalmitis after intravitreal injections of anti-vascular endothelial growth factor medications.眼科亚专业护理的并发症：玻璃体内注射抗血管内皮生长因子药物后的眼内炎。

Semin Ophthalmol. 2014 Sep-Nov;29(5-6):257-62. doi: 10.3109/08820538.2014.959616.

8

RELATIVE QUIESCENCE OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION AFTER RESOLUTION OF POSTINJECTION ENDOPHTHALMITIS.注射后眼内炎消退后渗出性年龄相关性黄斑变性相对静止。

Retina. 2020 Sep;40(9):1719-1723. doi: 10.1097/IAE.0000000000002666.

9

Leuconostoc as a Cause of Endophthalmitis Post-intravitreal Injection of Ranibizumab.嗜柠檬酸明串珠菌作为玻璃体内注射雷珠单抗后眼内炎的病因

Ocul Immunol Inflamm. 2016;24(1):118-9. doi: 10.3109/09273948.2014.898073. Epub 2014 Apr 21.

10

Endophthalmitis after Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors: Management and Visual Outcomes.眼内注射血管内皮生长因子抑制剂后的眼内炎：处理和视力结果。

Ophthalmology. 2018 Aug;125(8):1279-1286. doi: 10.1016/j.ophtha.2018.01.022. Epub 2018 Feb 21.

引用本文的文献

1

Profile of Patients Treated with Intravitreal Anti-Vascular Endothelial Growth Factor Injections in Bhutan.不丹接受玻璃体内抗血管内皮生长因子注射治疗的患者概况。

Clin Ophthalmol. 2023 Jun 2;17:1565-1573. doi: 10.2147/OPTH.S414621. eCollection 2023.

2

Endophthalmitis After Intravitreal Bevacizumab (Avastin) Injections: An Outbreak Investigated.玻璃体内注射贝伐单抗（阿瓦斯汀）后发生的眼内炎：一次爆发事件的调查

Cureus. 2023 Mar 27;15(3):e36769. doi: 10.7759/cureus.36769. eCollection 2023 Mar.